Cetera Trust Company’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Cetera Trust Company's HAE Position: Q3 2026 in Review
Cetera Trust Company held its Haemonetics (HAE) position steady in Q3 2026 at 4,670 shares worth $492K. The position accounts for 0.25% of the portfolio, ranked #77.
Cetera Trust Company first reported a position in HAE in Q3 2025 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Cetera Trust Company held 4,670 shares of Haemonetics worth $492K as of Q3 2026.
- Cetera Trust Company left its Haemonetics share count unchanged in Q3 2026.
- Haemonetics made up 0.25% of Cetera Trust Company's portfolio in Q3 2026, its #77 holding.
- Cetera Trust Company first reported a position in Haemonetics in Q3 2025 and has held it in 5 quarters since.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.